Research Grants Sample Clauses

Research Grants. ‌ During the life of this Agreement, the University shall provide annually at least one hundred sixty thousand dollars ($160,000) for research grants evaluated by the University Research Grant Committee. The grants provide funding for regular full-time tenure-track (not tenured) Assistant or Associate Professors, as well as Academic Staff, Teaching Faculty, Clinical Faculty, and Research Faculty in their first seven (7) years at WSU.
AutoNDA by SimpleDocs
Research Grants. Employees who have made funding or other project applications will be immediately notified of the approval/disapproval. The notification will include the project ranking. Any employee in the Department Research Program whose status and/or employment rights are altered or jeopardized, for example due to a change in funding, will be fully advised of the possible impact of such change at the time a change to their status is considered.
Research Grants. 14. In implementing Part 2(b) of the Project, the Recipient shall: (a) award the Research Grants to academic and research institutions in accordance with criteria set forth in the Research Grant Manual (RGM) in form and substance satisfactory to the Association; and (b) not amend or waive any provision of the RGM if such amendment or waiver may, in the opinion of the Association, materially or adversely affects the implementation of the Project.
Research Grants. UBC, SFU and EPM have demonstrated success in attracting research funding through grant agencies. They will explore the multitude of grants available. This is expected to include grants from the Canada Foundation for Innovation (CFI), International Development Research Centre (IDRC), tri-council (NSERC, SSHRC, CIHR), Western Economic Diversification (WED), and a number of other granting and charitable organizations which support policy development, poverty reduction, business and skills development, and international relief. Moreover, the partnerships engendered by the establishment of the Institute are anticipated to be able to leverage further funding from agencies such as NSERC (such as through the Industrial Research Chair program) and other governmental bodies.
Research Grants. Securing research funding is seen as a critical activity as the process is peer reviewed and competitive and hence indicative of the quality of research of the faculty. All faculty are required to make research proposal submissions an integral part of their research activity. Though research grants are largely extramural in nature, the institution also, in certain cases, may provide research grants to faculty based on merit and the importance to the institution of the proposed research in terms of its potential to place the institution at a strategic advantage in terms of national and global competitive research funding opportunities, or in terms of a substantial advantage provided by the research to serve critical needs of the community. The proportion of time devoted to teaching and research activities will vary from faculty to faculty and the institution reserves the right to stipulate limits as and when necessary to achieve the right balance for each faculty.
Research Grants. Section 1 Employees who apply for research grant funding or other project applications will be notified as soon as practicable of the approval/disapproval. The notification will include the project ranking.
Research Grants. Neither Progenics nor CYTOGEN shall, so long as such person is a member of the Company, apply to any funding source for a Research Grant in the Field unless such application is made for the benefit of the Company.
AutoNDA by SimpleDocs

Related to Research Grants

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Develop programs 1) The Employer will develop and implement health promotion and health education programs, subject to the availability of resources. Each Appointing Authority will develop a health promotion and health education program consistent with the Minnesota Management & Budget policy. Upon request of any exclusive representative in an agency, the Appointing Authority shall jointly meet and confer with the exclusive representative(s) and may include other interested exclusive representatives. Agenda items shall include but are not limited to smoking cessation, weight loss, stress management, health education/self-care, and education on related benefits provided through the health plan administrators serving state employees.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Licensed Technology The term “Licensed Technology” shall mean the Licensed Patent Rights, Licensed Know-How and Licensed Biological Materials.

  • Research Support opioid abatement research that may include, but is not limited to, the following:

  • Research License Each Collaborator shall allow the other Collaborator to practice any of its Non- Subject Inventions for the purpose of performing the Cooperative Work. No license, express or implied, for commercial application(s) is granted to either Collaborator in Non-Subject Inventions by performing the Cooperative Work. For commercial application(s) of Non-Subject Inventions, a license must be obtained from the owner.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

Time is Money Join Law Insider Premium to draft better contracts faster.